| | Drug | Target | Mechanism of action |
| | Zactima (ZD6474) | VEGFR, RET, EGFR (HER1) | Tyrosine kinase inhibitor | | XL184 | VEGFR2, MET, RET | Tyrosine kinase inhibitor | | Imatinib (STI571) | bcr-abl, PDGFR, C-KIT | Tyrosine kinase inhibitor | | Sorafinib (BAY-43-9006) | BRAF, CRAF, VEGFR, RET, PDGFR | Tyrosine kinase inhibitor | | Sunitinib (SU11248) | VEGFR, RET, PDGFR, C-KIT, CSF-1R, flt3 | Tyrosine kinase inhibitor | | AMG-706 | VEGFR1-3, PDGFR, C-KIT | Tyrosine kinase inhibitor | | Gefitinib | EGFR (HER1) | Tyrosine kinase inhibitor | | Axitinib (AG-013736) | VEGFR, PDGFR, C-KIT | Tyrosine kinase inhibitor | | Pazopanib (GW786034) | VEGFR1-3, PDGFR, C-KIT | Tyrosine kinase inhibitor | | SAHA | Notch1, TNF-α, IL-1-β, IL-6, IFN-γ | HDAC inhibitor | | Lithium | GSK-3ß | Unknown, suspected GSK3 inhibition, inositol depletion |
|
|
